A recent survey indicated that doctors in India spend an average of 2 minutes per patient in the OPD. While this number is awfully short, the perception of 'busy' doctor is often tied to being a 'good' doctor and patients favour seeking their professional opinion, even if it is only for '2 minutes'.

It is obvious that as the facetime with a patient gets shorter and shorter, a doctor is bound to miss important clinical findings which will reflect in poor decision making.

In this huddle, we discuss that for a 'busy' doctor, how busy is too busy where it starts effecting patient care directly.

The news had lately been flooded by the unexpected demise of a few celebrities who would have otherwise been considered at low risk for future ASCVD events. This triggered a discussion on how to predict such events. In our 76th session, we discuss this conundrum and try to address a few of the clinical aspects.

In the 75th session, we discussed iron deficiency anemia in males. While IDA is fairly common among females, it may signal major pathology among adult males, particularly malignancy. We discuss how to evaluate such patients and identify red flags.

Sugar substitutes, artificial sweeteners, or non-caloric sweeteners mostly refers to the same thing. In today's discussion, we try to address some of the myths and facts, and also share our opinion on this.

In the 73rd session, we discuss the role of indemnity (or professional liability) insurance among doctors. In the discussion, I am joined by Dr. Neeraj Nagpal who is a Delhi based doctor and expert in indemnity insurance.

In our 72nd session, we discuss bronchodilator therapy in cardiac patients, in particular, the mode of drug delivery

Our new year special session. In this, we discuss various aspects of protein supplements, particularly in reference to resistance training (muscle building). We hear from doctors who have expertise in this field, and dietetics experts.

On World Heart Day, we discussed the role of Influenza vaccines in the Indian context.

In the 70th session, we discuss the differences between various preparations of nitrates that are available in the market. The discussion addresses the pharmacokinetics of short vs long-acting nitrates and how it affects clinical management.

In this session, we discuss the newly published EMPEROR-Preserved trial in a 'casual' journal club format. We discuss the merits of this particular trial, how it changes our practice, and how to critically analyze trials as a general